Strategy (MSTR) stock hits a 52-week low as bitcoin slides — what traders watch next

Strategy (MSTR) stock hits a 52-week low as bitcoin slides — what traders watch next

NEW YORK, Jan 29, 2026, 12:10 EST — Regular session

  • cshares plunged midday, following a new dip in bitcoin prices.
  • Crypto-related miners and exchanges dropped as investors pulled back on risk.
  • All eyes shift to Strategy’s Feb. 5 earnings and any news on its bitcoin approach.

Strategy Inc shares dropped 9.7% to $143.06 on Thursday, hitting a low of $141.63 — the bottom of their 52-week range — as the bitcoin-linked stock remained under pressure during regular hours. 1

The company, once known as MicroStrategy, has repositioned itself as a bitcoin treasury firm while continuing its enterprise analytics software operations. Its stock frequently moves like a leveraged play on the cryptocurrency. 2

Bitcoin dropped 5.23% in the last 24 hours, slipping to roughly $84,915, putting pressure on crypto-linked stocks. 3

The sell-off extended through the sector. MARA Holdings slipped 6%, Riot Platforms lost 7%, and Coinbase dipped 6.5% as bitcoin hit a session low of $84,233, according to Investing.com. 4

The broader environment weighed on markets, as big tech slumped and pulled major U.S. indexes down. Microsoft dropped over 11%, while Apple’s earnings report is expected after the close. “Maybe a bit of de-risking going into the print,” noted Adam Turnquist, chief technical strategist at LPL Financial. 5

Crypto traders are eyeing whether the macro environment tightens again after the Fed’s recent pause, and if money flows back into bitcoin exchange-traded funds — those popular listed vehicles for accessing the token without owning it outright. “Crypto markets appear locked in consolidation-active, but waiting for a decisive macro or technical catalyst,” said Riya Sehgal, a research analyst at Delta Exchange. 6

Strategy’s recent pullback highlights how its swings can outpace bitcoin’s. The stock now serves as a barometer for risk appetite, often gapping sharply when the token crosses or defends critical thresholds.

That link works both ways. Should bitcoin’s slide deepen, Strategy’s equity could tank quickly; if the token steadies, the stock might rebound sharply, putting shorts at risk of sudden squeezes.

Investors are set to focus on Strategy’s Q4 results, dropping Feb. 5 after U.S. markets close, along with the company’s 5 p.m. Eastern webcast. They’ll be hunting for clues on buying momentum and financing plans, especially since Strategy relies on equity, debt, and operating cash flow to build its bitcoin holdings. 7

Stock Market Today

Citigroup stock price jumps as consent-order exit comes back into focus

Citigroup stock price jumps as consent-order exit comes back into focus

7 February 2026
Citigroup shares jumped 6% to $122.69 Friday before holding steady after hours, as executives grew more confident about resolving longstanding regulatory consent orders this year, sources said. The Dow closed above 50,000 for the first time, gaining 2.47%. Citi also announced it will match the U.S. government’s $1,000 “Trump Accounts” contribution for eligible employees’ families.
MercadoLibre stock slides into the weekend as the market rallies — what MELI investors watch next

MercadoLibre stock slides into the weekend as the market rallies — what MELI investors watch next

7 February 2026
MercadoLibre shares fell 3.18% to $1,970.15 Friday, bucking a broad U.S. market rally. The stock has dropped about 6% over four sessions as traders await fourth-quarter results, provisionally set for Feb. 24. Analysts expect earnings per share of $11.66, down 7.5% from last year, with revenue up 40% to $8.49 billion. Margins, currency swings, and credit trends in Brazil, Mexico, and Argentina remain in focus.
Exxon Mobil stock price rises as oil jumps and earnings loom — what traders watch for XOM
Previous Story

Exxon Mobil stock price rises as oil jumps and earnings loom — what traders watch for XOM

Johnson & Johnson stock price drifts after record-area run as Morgan Stanley upgrade keeps spotlight on new drugs
Next Story

Johnson & Johnson stock price drifts after record-area run as Morgan Stanley upgrade keeps spotlight on new drugs

Go toTop